The Motley Fool Discussion Boards

Previous Page

Stocks C / Celera


Subject:  Bye Bye Celera Date:  3/25/2011  2:48 PM
Author:  ShouldKnowBetter Number:  36499 of 36502

Quest is buying Celera for 8.00 a share

Quest Diagnostics (NYSE:DGX) is certainly not shy about spending shareholders' money to expand its business opportunities. Quest's latest deal, announced Friday morning, will have the company paying $8 per share in cash to acquire all of Celera (NYSE:CRA), a small company with a focus on molecular diagnostics and cardiovascular tests.

Copyright 1996-2022 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us